These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25250200)

  • 1. Kinetic modeling in PET imaging of hypoxia.
    Li F; Joergensen JT; Hansen AE; Kjaer A
    Am J Nucl Med Mol Imaging; 2014; 4(6):490-506. PubMed ID: 25250200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparative Study of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole PET/CT in Patients with Lung Cancer.
    Wei Y; Zhao W; Huang Y; Yu Q; Zhu S; Wang S; Zhao S; Hu X; Yu J; Yuan S
    PLoS One; 2016; 11(6):e0157606. PubMed ID: 27322586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].
    Furukawa T; Yuan Q; Jin ZH; Aung W; Yoshii Y; Hasegawa S; Endo H; Inoue M; Zhang MR; Fujibayashi Y; Saga T
    Oncol Rep; 2015 Sep; 34(3):1379-87. PubMed ID: 26134305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling.
    Bowen SR; van der Kogel AJ; Nordsmark M; Bentzen SM; Jeraj R
    Nucl Med Biol; 2011 Aug; 38(6):771-80. PubMed ID: 21843774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers.
    Carlin S; Zhang H; Reese M; Ramos NN; Chen Q; Ricketts SA
    J Nucl Med; 2014 Mar; 55(3):515-21. PubMed ID: 24491409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic Evaluation of the Hypoxia Radiotracers [
    Choen S; Kent MS; Chaudhari AJ; Cherry SR; Krtolica A; Zwingenberger AL
    Nucl Med Mol Imaging; 2023 Feb; 57(1):16-25. PubMed ID: 36643946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography.
    Matsumoto K; Szajek L; Krishna MC; Cook JA; Seidel J; Grimes K; Carson J; Sowers AL; English S; Green MV; Bacharach SL; Eckelman WC; Mitchell JB
    Int J Oncol; 2007 Apr; 30(4):873-81. PubMed ID: 17332926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
    O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.
    Sorger D; Patt M; Kumar P; Wiebe LI; Barthel H; Seese A; Dannenberg C; Tannapfel A; Kluge R; Sabri O
    Nucl Med Biol; 2003 Apr; 30(3):317-26. PubMed ID: 12745023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introducing fluorine-18 fluoromisonidazole positron emission tomography for the localisation and quantification of pig liver hypoxia.
    Piert M; Machulla H; Becker G; Stahlschmidt A; Patt M; Aldinger P; Dissmann PD; Fischer H; Bares R; Becker HD; Lauchart W
    Eur J Nucl Med; 1999 Feb; 26(2):95-109. PubMed ID: 9933343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron Emission Tomography (PET) and Pharmacokinetics: Classical Blood Sampling Versus Image-Derived Analysis of [18F]FAZA and [18F]FDG in a Murine Tumor Bearing Model.
    Jans HS; Yang XH; Brocks DR; Kumar P; Wuest M; Wiebe LI
    J Pharm Pharm Sci; 2018; 21(1s):32s-47s. PubMed ID: 29702045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for PET imaging of hypoxia--a simulation study.
    Wack LJ; Mönnich D; van Elmpt W; Zegers CM; Troost EG; Zips D; Thorwarth D
    Acta Oncol; 2015; 54(9):1370-7. PubMed ID: 26203928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.
    Reischl G; Dorow DS; Cullinane C; Katsifis A; Roselt P; Binns D; Hicks RJ
    J Pharm Pharm Sci; 2007; 10(2):203-11. PubMed ID: 17706178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
    Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM
    J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of hypoxic PET using (18)F-FAZA and (62)Cu-ATSM in non-small-cell lung cancer.
    Kinoshita T; Fujii H; Hayashi Y; Kamiyama I; Ohtsuka T; Asamura H
    Lung Cancer; 2016 Jan; 91():56-66. PubMed ID: 26711935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.
    Chao KS; Bosch WR; Mutic S; Lewis JS; Dehdashti F; Mintun MA; Dempsey JF; Perez CA; Purdy JA; Welch MJ
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1171-82. PubMed ID: 11240261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.
    Stieb S; Eleftheriou A; Warnock G; Guckenberger M; Riesterer O
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2201-2217. PubMed ID: 30128659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic Analysis of (64)Cu-ATSM Dynamic PET in Human Xenograft Tumors in Mice.
    Li F; Jørgensen JT; Madsen J; Kjaer A
    Diagnostics (Basel); 2015 Mar; 5(2):96-112. PubMed ID: 26854145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer.
    Thureau S; Piton N; Gouel P; Modzelewski R; Dujon A; Baste JM; Melki J; Rinieri P; Peillon C; Rastelli O; Lequesne J; Hapdey S; Sabourin JC; Bohn P; Vera P
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing hypoxia in human glioma: A simultaneous multimodal MRI and PET study.
    Preibisch C; Shi K; Kluge A; Lukas M; Wiestler B; Göttler J; Gempt J; Ringel F; Al Jaberi M; Schlegel J; Meyer B; Zimmer C; Pyka T; Förster S
    NMR Biomed; 2017 Nov; 30(11):. PubMed ID: 28805936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.